Company intelligence / Profile preview

Kangyuan Biomedical Technology

Qingdao, Shandong, China

Ownership: Private
Development stage: Other

Overview

Leading Chinese manufacturer of medical devices, hormone APIs (active pharmaceutical ingredients), and diagnostic tools; products include recombinant and natural biologics (FSH, HMG, urokinase), medical consumables, and innovative blood purification and diagnostic technologies. Company has ISO and GMP certifications and supplies both the domestic and international market

Therapeutic areas: EndocrinologyHematologyCardiovascularOtherWomen's Health
Modalities: BiologicSmall moleculeProteinPeptidesMonoclonal antibodyNano-antibodyMedical device
Industry: Biotech

Partnerships

Chinese Academy of Sciences

Beyond the preview

Go deeper on Kangyuan Biomedical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kangyuan Biomedical Technology.

Explore the full profile